LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapies Eiger BioPharmaceuticals focuses on developing innovative therapies for rare metabolic diseases, such as avexitide for post-bariatric hypoglycemia and congenital hyperinsulinism. These unique products present sales opportunities in niche markets with high unmet medical needs.

Chapter 11 Developments Despite Chapter 11 bankruptcy proceedings, Eiger BioPharmaceuticals has been making strategic decisions to sell assets to companies like Amylyx Corp. Sales development representatives can leverage these financial maneuvers to explore partnerships or acquisitions that align with the company's goals.

Expansion in Therapeutic Areas With a focus on developing solutions for hepatitis delta virus infection using peginterferon lambda, Eiger BioPharmaceuticals is expanding into new therapeutic areas. Sales professionals may tap into this diversification to explore collaborations and sales opportunities in the infectious disease treatment landscape.

Key Personnel Transition The promotion of Apelian to interim CEO at Eiger BioPharmaceuticals signifies a shift in leadership and strategic direction. Sales development representatives can capitalize on building relationships with new key decision-makers and understanding their vision for potential growth and partnerships.

Revenue and Financials Eiger BioPharmaceuticals has a revenue range of $10M - $50M and secured funding of $5M. Understanding the financial stability and growth potential of the company can guide sales development representatives in tailoring value propositions to align with Eiger's financial capacity and goals.

Eiger BioPharmaceuticals Tech Stack

Eiger BioPharmaceuticals uses 8 technology products and services including jQuery CDN, WordPress, NetSuite, and more. Explore Eiger BioPharmaceuticals's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • NetSuite
    E-commerce
  • WooCommerce
    E-commerce
  • Acquia Cloud Platform
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Bootstrap
    UI Frameworks
  • Drupal Multisite
    Web Hosting

Media & News

Eiger BioPharmaceuticals's Email Address Formats

Eiger BioPharmaceuticals uses at least 1 format(s):
Eiger BioPharmaceuticals Email FormatsExamplePercentage
FLast@eigerbio.comJDoe@eigerbio.com
49%
LFirst@eigerbio.comDJohn@eigerbio.com
1%
Last@eigerbio.comDoe@eigerbio.com
1%
FLast@eigerbio.comJDoe@eigerbio.com
49%

Frequently Asked Questions

Where is Eiger BioPharmaceuticals's headquarters located?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's main headquarters is located at US. The company has employees across 4 continents, including North AmericaEuropeSouth America.

What is Eiger BioPharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Eiger BioPharmaceuticals's main corporate office by phone at +1-650-272-6138. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eiger BioPharmaceuticals's stock symbol?

Minus sign iconPlus sign iconEiger BioPharmaceuticals is a publicly traded company; the company's stock symbol is EIGRQ.

What is Eiger BioPharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's official website is eigerbio.com and has social profiles on LinkedIn.

How much revenue does Eiger BioPharmaceuticals generate?

Minus sign iconPlus sign icon As of June 2024, Eiger BioPharmaceuticals's annual revenue reached $12M.

What is Eiger BioPharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's SIC code is 8661 - Religious Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eiger BioPharmaceuticals have currently?

Minus sign iconPlus sign iconAs of June 2024, Eiger BioPharmaceuticals has approximately 26 employees across 4 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: D. A.Chief Business Officer: I. C.Chief Business Officer: J. S.. Explore Eiger BioPharmaceuticals's employee directory with LeadIQ.

What industry does Eiger BioPharmaceuticals belong to?

Minus sign iconPlus sign iconEiger BioPharmaceuticals operates in the Biotechnology Research industry.

What technology does Eiger BioPharmaceuticals use?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's tech stack includes jQuery CDNWordPressNetSuiteWooCommerceAcquia Cloud PlatformYoast SEOBootstrapDrupal Multisite.

What is Eiger BioPharmaceuticals's email format?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's email format typically follows the pattern of . Find more Eiger BioPharmaceuticals email formats with LeadIQ.

How much funding has Eiger BioPharmaceuticals raised to date?

Minus sign iconPlus sign icon As of June 2024, Eiger BioPharmaceuticals has raised $5M in funding. The last funding round occurred on Jun 07, 2022 for $5M.
Eiger BioPharmaceuticals

Eiger BioPharmaceuticals

Biotechnology ResearchUnited States11-50 Employees

Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases. Eiger's lead product candidate, avexitide, is a well characterized, first-in-class GLP-1 antagonist for the treatment of post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism (HI). Avexitide is the only drug in development for PBH with Breakthrough Therapy designation from the FDA.
 
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.

For our social media and community guidelines, including information on how to report adverse events, please visit www.eigerbio.com/social-media-guidelines/

Section iconCompany Overview

Headquarters
US
Phone number
+1-650-272-6138
Website
eigerbio.com
SIC Code
8661 - Religious Organizations
Stock Symbol
EIGRQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5M

    Eiger BioPharmaceuticals has raised a total of $5M of funding over 10 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $5M.

  • $10M$50M

    Eiger BioPharmaceuticals's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $5M

    Eiger BioPharmaceuticals has raised a total of $5M of funding over 10 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $5M.

  • $10M$50M

    Eiger BioPharmaceuticals's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.